Sonde wants to lis­ten for dis­ease — M Ven­tures heard the Boston biotech, and led a $16M round to su­per­charge re­search

Sight, touch and even smell are in­tu­itive and large­ly sci­en­tif­i­cal­ly-backed tools used to di­ag­nose dis­ease, and re­searchers are even eval­u­at­ing the clin­i­cal po­ten­tial …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.